PLX PHARMA INC (PLXP) Stock Price, Quote, News and Overview
NASDAQ:PLXP - Nasdaq - US72942A1079 - Common Stock - Currency: USD
PLXP Quote, Performance and Key Statistics
0.087
-0.03 (-27.8%)
The current stock price of PLXP is 0.087 USD. In the past month the price decreased by -43.51%. In the past year, price decreased by -97.52%.
PLXP Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 68.19 | 841.60B | ||
| NVO | NOVO-NORDISK A/S-SPONS ADR | 28.13 | 400.82B | ||
| JNJ | JOHNSON & JOHNSON | 16.35 | 393.32B | ||
| AZN | ASTRAZENECA PLC-SPONS ADR | 20.74 | 232.18B | ||
| MRK | MERCK & CO. INC. | 11.85 | 229.03B | ||
| NVS | NOVARTIS AG-SPONSORED ADR | 13.8 | 216.45B | ||
| PFE | PFIZER INC | 8.5 | 149.75B | ||
| SNY | SANOFI-ADR | 13.45 | 135.25B | ||
| BMY | BRISTOL-MYERS SQUIBB CO | 50.37 | 116.46B | ||
| GSK | GSK PLC-SPON ADR | 7.87 | 75.60B | ||
| ZTS | ZOETIS INC | 27.71 | 74.01B | ||
| TAK | TAKEDA PHARMACEUTIC-SP ADR | 32.07 | 44.73B |
Related stock screener links
About PLXP
Company Profile
PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of technology platform for approved drugs. The company is headquartered in Sparta, New Jersey and currently employs 16 full-time employees. The company went IPO on 2014-03-13. The firm has two commercialized products, VAZALORE 81 milligram (mg) and VAZALORE 325 mg, which are liquid-filled aspirin capsules for over the counter (OTC) distribution. The firm markets VAZALORE to the healthcare professional and the consumer through several sales and marketing channels. Its product pipeline also includes other oral NSAIDs using the PLxGuard drug delivery platform, including PL1200 Ibuprofen 200 mg and PL1100 Ibuprofen 400 mg, for pain and inflammation in Phase I clinical stage. PLxGuard drug delivery platform employs a pH-dependent release mechanism that relies on association of lipidic excipients with APIs for targeted release in the GI tract.
Company Info
PLX PHARMA INC
9 Fishers Ln Ste E
Sparta NEW JERSEY 07871 US
CEO: Natasha Giordano
Employees: 16
Company Website: https://plxpharma.com
Phone: 17138421249.0
PLX PHARMA INC / PLXP FAQ
What is the stock price of PLX PHARMA INC today?
The current stock price of PLXP is 0.087 USD. The price decreased by -27.8% in the last trading session.
What is the ticker symbol for PLX PHARMA INC stock?
The exchange symbol of PLX PHARMA INC is PLXP and it is listed on the Nasdaq exchange.
On which exchange is PLXP stock listed?
PLXP stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for PLX PHARMA INC stock?
6 analysts have analysed PLXP and the average price target is 11.22 USD. This implies a price increase of 12796.55% is expected in the next year compared to the current price of 0.087. Check the PLX PHARMA INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is PLX PHARMA INC worth?
PLX PHARMA INC (PLXP) has a market capitalization of 2.53M USD. This makes PLXP a Nano Cap stock.
How many employees does PLX PHARMA INC have?
PLX PHARMA INC (PLXP) currently has 16 employees.
Is PLX PHARMA INC (PLXP) expected to grow?
The Revenue of PLX PHARMA INC (PLXP) is expected to decline by -57.24% in the next year. Check the estimates tab for more information on the PLXP EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy PLX PHARMA INC (PLXP) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of PLXP, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of PLXP, evaluating the profitability, health, valuation and growth aspects
- PLX PHARMA INC (PLXP) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- PLX PHARMA INC (PLXP) Sales and EPS estimates to see what analysts future expectations are.
- PLX PHARMA INC (PLXP) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- PLX PHARMA INC (PLXP) Insider and Institutional Ownership to learn about the owners and their transactions.
- PLX PHARMA INC (PLXP) Stock Chart to make your own analysis
- PLX PHARMA INC (PLXP) Latest news and press-releases to stay up to date.
Does PLX PHARMA INC (PLXP) stock pay dividends?
PLXP does not pay a dividend.
When does PLX PHARMA INC (PLXP) report earnings?
PLX PHARMA INC (PLXP) will report earnings on 2023-05-11.
What is the Price/Earnings (PE) ratio of PLX PHARMA INC (PLXP)?
PLX PHARMA INC (PLXP) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.02).
PLXP Technical Analysis
PLXP Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to PLXP. PLXP has a bad profitability rating. Also its financial health evaluation is rather negative.
PLXP Financial Highlights
Over the last trailing twelve months PLXP reported a non-GAAP Earnings per Share(EPS) of -1.02. The EPS increased by 68.03% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | N/A | ||
| ROE | N/A | ||
| Debt/Equity | 0 |
PLXP Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to PLXP. The Buy consensus is the average rating of analysts ratings from 6 analysts.
For the next year, analysts expect an EPS growth of 36.14% and a revenue growth -57.24% for PLXP